Molecular analysis integrating different pathways associated with androgen-independent progression in LuCaP 23.1 xenograft

Oncogene

Volumn 23, Issue 56, 2004, Pages 9111-9119

  Rocchi, Palma ^a,c   Muracciole, Xavier ^b   Fina, Frederic ^a   Mulholland, Dave J ^c   Karsenty, Gilles ^d   Palmari, Jacqueline ^a   Ouafik, L'Haucine ^a   Bladou, Franck ^d   Martin, Pierre Marie ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b TIMONE HOSPITAL   (France)

^c JACK BELL RESEARCH CENTRE   (Canada)

^d Child and Adolescent Psychopathology Unit Salvator Hospital Public Assistance Marseille Hospitals University Aix Marseille II   (France)

Author keywords

Androgen independence; LuCaP 23.1 xenograft; Molecular expression analysis; Prostate cancer

Indexed keywords

ALPHA AMIDATING ENZYME; ANDROGEN; MESSENGER RNA; MOLECULAR MARKER; THYMIDYLATE SYNTHASE;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASTRATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TARGETING; GENETIC ANALYSIS; GROWTH INHIBITION; MALE; MOLECULAR GENETICS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR GROWTH; TUMOR MODEL; TUMOR XENOGRAFT;

ANDROGENS; ANIMALS; CELL LINE, TUMOR; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; ORCHIECTOMY; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSPLANTATION, HETEROLOGOUS;

ANIMALIA; MUS MUSCULUS;

EID: 10944221722     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208154     Document Type: Article

References (43)

1. Abrahamsson PA. (1999). Prostate, 39, 135-148.
2. Bladou F, Vessella RL, Buhler KR, Ellis WJ, True LD and Lange PH. (1996). Int. J. Cancer, 67, 785-790.
3. Buttyan R, Ghafar M-A, Shabsigh A, Solit D-B, Zheng F-F, Drobnjak M, Munster P-N, Higgins B, Verbel D, Heller G, Tong W, Cordon-Cardo C, Agus D-B, Scher H-I and Rosen N. (2000). Curr. Opin. Urol., 10, 415-420.
4. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
5. Craft N, Shostak Y, Carey M and Sawyers CL. (1999). Nat. Med., 5, 280-285.
6. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G and Klocker H. (1994). Cancer Res., 54, 5474-5478.
7. Dahiya R, Lee C, Haughney PC, Chui R, Ho R and Deng G. (1996). Urology, 48, 963-970.
8. Delos S, Carsol JL, Fina F, Raynaud JP and Martin PM. (1998). Int. J. Cancer, 75, 840-846.
9. Denis L-J and Griffiths K. (2000). Semin. Surg. Oncol., 18, 52-74.
10. Ellis WJ, Vessella RL, Buhler KR, Bladou F, True LD, Bigler SA, Curtis D and Lange PH. (1996). Clin. Cancer Res., 2, 1039-1048.
11. Feldman BJ and Feldman D. (2001). Nat. Rev. Cancer, 1, 34-45.
12. Gaylis FD, Keer HN, Wilson MJ, Kwaan HC, Sinha AA and Kozlowski JM. (1989). J. Urol., 142, 193-198.
13. Gleave ME, Tolcher A, Miyake H, Beraldi E and Goldie J. (1999). Clin. Cancer Res., 5, 2891-2898.
14. Helenius MA, Saramäki OR, Linja MJ, Tammel TLJ and Visakorpi T. (2001). Cancer Res., 61, 5340-5344.
15. Hollas W, Hoosein N, Chung LW, Mazar A, Henkin J, Kariko K, Barnathan ES and Boyd D. (1992). Thromb. Haemost., 68, 662-666.
16. Huss WJ, Hanrahan CF, Barrios RJ, Simons JW and Greenberg NM. (2001). Cancer Res., 61, 2736-2743.
17. Janik P, Briand P and Hartman NR, (1975). Cancer Res., 35, 3698-3704.
18. Jenster G, Denis LJ and Griffiths K. (1999). Semin. Oncol., 26, 407-421.
19. Joliffe IT and Morgan BJ. (1992). Stat. Methods Med. Res., 1, 69-95.
20. Koivisto P, Kononen J, Palmberg C, Tammela T, Hyytinen E, Isola J, Trapman J, Cleutjens K, Noordzij A, Visakorpi T and Kallioniemi OP. (1997). Cancer Res., 57, 314-319.
21. Landström M, Damber JE and Bergh A. (1994). Cancer Res., 54, 4281-4284.
22. Liu AY, Corey E, Bladou F, Lange PH and Vessella RL. (1996). Int. J. Cancer, 65, 85-89.
23. Lyon PB, See WA, Xu Y and Cohen MB. (1995). Prostate, 27, 179-186.
24. McGowen R, Biliran Jr H, Sager R and Sheng S. (2000). Cancer Res., 60, 4771-4778.
25. McLeod DG. (2003). Urology, 61, 3-7.
26. Miyake H, Tolcher A and Gleave ME. (1999). Cancer Res., 59, 4030-4034.
27. Negri-Cesi P, Colciago A, Poletti A and Motta M. (1999). Prostate, 41, 224-232.
28. Nelson JB and Carducci MA. (2000a). Cancer Invest., 18, 87-96.
29. Nelson JB and Carducci MA. (2000b). BJU Int., 85 (Suppl 2), 45-48.
30. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP and Nanus DM. (1998). Nat. Med., 4, 50-57.
31. Parker SL, Tong T, Bolden S and Wingo PA. (1996). Cancer J. Clin., 46, 5-27.
32. Rocchi P, Boudouresque F, Zamora AJ, Muracciole X, Lechevallier E, Martin PM and Ouafik LH. (2001). Cancer Res., 61, 1196-1206.
33. Ross RK, Pike MC, Coetzee GA, Reichardt JK, Yu MC, Feigelson H, Stanczyk FZ, Kolonel LN and Henderson BE. (1998). Cancer Res., 58, 4497-4504.
34. Scher HI. (2000). J. Nalt. Cancer Inst., 92, 1866-1868.
35. Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendelsohn J and Cordon-Cardo C. (1995). Clin. Cancer Res., 1, 545-550.
36. Solit DB, Zheng FF, Drobnjak M, Munster PN, Higgins B, Verbel D, Heller G, Tong W, Cordon-Cardo C, Agus DB, Scher HI and Rosen N. (2002). Clin Cancer Res., 8, 986-993.
37. Turkeri LN, Sakr WA, Wykes SM, Grignon DJ, Pontes JE and Macoska JA. (1994). Prostate, 25, 199-205.
38. Visakorpi T, Hyytinen E, Koivisto P, Tanner M, Keinanen R, Palmberg C., Palotie A, Tammela T, Isola J and Kallioniemi OP. (1995). Nat. Genet., 9, 401-406.
39. Wen Y, Hu MC, Makino K, Spohn B, Bartholomeusz G, Yan DH and Hung MC. (2000). Cancer Res., 60, 6841-6845.
40. Xing RH and Rabbani SA. (1999). Endocrinology, 140, 4056-4064.
41. Yeh S, Lin HK, Kang HY, Thin TH, Lin MF and Chang C. (1999). Proc. Natl. Acad. Sci. USA, 96, 5458-5463.
42. Zhang L, Johnson M, Le KH, Sato M, Ilagan R, Iyer M, Gambhir SS, Wu L and Carey M. (2003). Cancer Res., 63, 4552-4560.
43. Zudaire E, Martinez A and Cuttitta F. (2003). Regul. Peptides, 112, 175-183.